Aesthetic Medical International Holdings
AIH was delisted on the 20th of May, 2024.
5 hedge funds and large institutions have $849K invested in Aesthetic Medical International Holdings in 2022 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
17% less funds holding
Funds holding: 6 → 5 (-1)
28% less capital invested
Capital invested by funds: $1.17M → $849K (-$324K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$383 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$21K |
AIH Hedge Fund Activity: Q4 2022 in Review
5 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Aesthetic Medical International Holdings (AIH) for Q4 2022, worth a combined $849K — down 28% from $1.17M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of AIH and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 1 added.
The largest buyer was UBS Group, adding an estimated $383. The largest seller was Citadel Advisors, exiting entirely with an estimated $21K sold.
- 5 institutional investors held Aesthetic Medical International Holdings (AIH) as of Q4 2022, down from 6 in Q3 2022.
- Funds reported $849K of Aesthetic Medical International Holdings stock for Q4 2022, down 28% quarter-over-quarter.
- 0 funds opened new Aesthetic Medical International Holdings positions in Q4 2022 and 1 closed out, a net change of -1 holder.
- The largest Aesthetic Medical International Holdings buyer in Q4 2022 was UBS Group, an estimated $383 added.
- The largest Aesthetic Medical International Holdings seller in Q4 2022 was Citadel Advisors, an estimated $21K sold.
Based on aggregated 13F filings for Q4 2022.